Johnson & Johnson (JNJ) Cash & Current Investments (2009 - 2026)

Johnson & Johnson (JNJ) posted Cash & Current Investments of $22.1 billion for Q1 2026, up 9.7% sequentially from $20.1 billion in Q4 2025, and down 43.14% YoY from $38.8 billion in Q1 2025.

Johnson & Johnson (JNJ) Cash & Current Investments (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Cash & Current Investments data on file, last reported at $22.1 billion in Q1 2026.

  • Quarterly Cash & Current Investments fell 43.14% year-over-year to $22.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.1 billion (down 43.14% YoY) and the FY2025 annual result came in at $20.1 billion, down 18.02% from the prior year.
  • Cash & Current Investments grew to $22.1 billion in Q1 2026 per JNJ's latest filing, from $20.1 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $38.8 billion in Q1 2025, with the low at $18.6 billion in Q3 2025.
  • Average Cash & Current Investments over 5 years is $25.9 billion, with a median of $24.6 billion recorded in 2023.
  • Year-over-year, Cash & Current Investments surged 47.92% in 2025 and sank 43.14% in 2026.
  • Johnson & Johnson's Cash & Current Investments stood at $34.1 billion in 2022, then slumped by 32.72% to $22.9 billion in 2023, then grew by 6.96% to $24.5 billion in 2024, then slipped by 18.02% to $20.1 billion in 2025, then increased by 9.7% to $22.1 billion in 2026.
  • Business Quant data shows JNJ's Cash & Current Investments at $22.1 billion in Q1 2026, $20.1 billion in Q4 2025, and $18.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.28 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 22.05 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 9.39 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 7.94 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 5.70 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 12.04 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 7.64 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 13.08 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 100.00 Mn
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 4.28 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 22.05 Bn
Dec 28, 2025 20.10 Bn
Sep 28, 2025 18.56 Bn
Jun 29, 2025 18.88 Bn
Mar 30, 2025 38.78 Bn
Dec 29, 2024 24.52 Bn
Sep 29, 2024 20.30 Bn
Jun 30, 2024 25.48 Bn
Mar 31, 2024 26.22 Bn
Dec 31, 2023 22.93 Bn
Oct 1, 2023 23.51 Bn
Jul 2, 2023 28.51 Bn
Apr 2, 2023 24.61 Bn
Jan 1, 2023 22.28 Bn
Oct 2, 2022 34.08 Bn
Jul 3, 2022 32.57 Bn
Apr 3, 2022 30.39 Bn
Jan 2, 2022 31.61 Bn
Oct 3, 2021 31.00 Bn
Jul 4, 2021 25.31 Bn